Analysts expect Radiopharm Theranostics Ltd to report revenue of 1.55 M for 2027, against a range of 1.43 M to 1.68 M. The most recent reported year, 2026, came in at 1.98 M, a 28.4% beat against the 1.54 M consensus.
| Metric | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | 189,350.00 | 203,030.00 | 2.38 M | 1.98 M | - | - | ||
| High Estimate | 223,625.56 | 0.00 | 795,635.25 | 1.69 M | 1.68 M | 2.14 M | ||
| Low Estimate | 188,880.58 | 0.00 | 740,621.89 | 1.39 M | 1.43 M | 1.81 M | ||
| Consensus Estimate | 206,253.07 | 0.00 | 768,128.57 | 1.54 M | 1.55 M | 1.98 M |
Analysts expect Radiopharm Theranostics Ltd to report earnings per share of -2.08 for 2027, against a range of -2.18 to -1.98. The most recent reported year, 2026, came in at -3.85, a 61.8% miss against the -2.38 consensus.
| Metric | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|---|---|---|---|
| Reported (Actual) | -31.54 | -20.79 | -25.29 | -3.46 | -3.85 | - | - | ||
| High Estimate | -20.60 | -15.49 | -18.42 | -4.49 | -2.25 | -1.98 | -1.81 | ||
| Low Estimate | -23.90 | -18.27 | -22.40 | -5.19 | -2.51 | -2.18 | -2.15 | ||
| Consensus Estimate | -22.25 | -16.88 | -20.41 | -4.84 | -2.38 | -2.08 | -1.98 |
Pull Wall Street consensus for Radiopharm Theranostics Ltd (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/estimates?ticker=RADX&mode=revenue&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/estimates"
params = {"ticker": "RADX", "mode": "revenue", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/estimates?ticker=RADX&mode=revenue&api_key=YOUR_API_KEY");
const data = await res.json();